Share Price and Basic Stock Data
Last Updated: October 13, 2025, 8:58 pm
PEG Ratio | 0.15 |
---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Gillanders Arbuthnot & Company Ltd operates within the Plantations sector, specifically focusing on tea and coffee. As of the latest reports, the company’s share price stood at ₹126, with a market capitalization of ₹269 Cr. Over the last few quarters, the company has shown fluctuating revenue trends. Sales recorded in June 2022 were ₹124.81 Cr, which increased to ₹143.56 Cr in September 2022, before declining to ₹77.42 Cr by March 2023. In the subsequent quarters, revenue rebounded, with ₹105.42 Cr reported in September 2023, though it faced a dip again in December 2023 to ₹101.43 Cr. For FY 2025, sales are recorded at ₹443 Cr, demonstrating a recovery from the previous fiscal year’s ₹363 Cr. These trends indicate volatility in the company’s revenue generation, reflecting challenges in maintaining consistent sales performance amidst market fluctuations.
Profitability and Efficiency Metrics
In terms of profitability, Gillanders Arbuthnot has faced significant challenges, particularly evident from its operating profit margins (OPM), which reported a concerning -0.14% overall. The quarterly OPM has fluctuated dramatically, with a peak of 16.79% in September 2022, while it fell to -24.33% in December 2023. The net profit for FY 2025 recorded a figure of ₹27 Cr, contrasting sharply with the losses of ₹49 Cr in FY 2024. The company’s return on equity (ROE) stood at a modest 6.83%, while the return on capital employed (ROCE) was slightly lower at 6.80%. A significant risk is highlighted by the interest coverage ratio, which declined to -1.40x, suggesting that the company struggles to meet its interest obligations. This financial strain raises concerns about long-term sustainability and operational efficiency.
Balance Sheet Strength and Financial Ratios
Examining Gillanders Arbuthnot’s balance sheet reveals a mixed picture. The company reported total reserves of ₹224 Cr against borrowings of ₹139 Cr, indicating a relatively healthy liquidity position. However, the current ratio, which stood at 0.85, suggests potential liquidity issues, as it falls below the generally acceptable benchmark of 1. The debt-to-equity ratio was noted at 0.53, showing that the company is moderately leveraged. Over the years, the asset turnover ratio has shown some resilience, standing at 0.70%, but this is lower than sector norms, indicating inefficiencies in asset utilization. With fixed assets declining from ₹312 Cr in FY 2022 to ₹263 Cr in FY 2024, there is a need for the company to manage its assets more effectively to enhance profitability and operational performance.
Shareholding Pattern and Investor Confidence
Investor confidence in Gillanders Arbuthnot appears relatively stable, with promoters holding a substantial 69.05% stake, indicating a strong commitment to the company. The presence of foreign institutional investors (FIIs) remains minimal at 0.00%, while domestic institutional investors (DIIs) account for only 0.31%. Public shareholding stands at 30.60%, with the total number of shareholders rising to 10,447, reflecting a growing interest among retail investors. However, the low institutional participation might raise concerns about the stock’s appeal among larger investors. The stability of promoter holding over time suggests confidence in the company’s long-term strategy, but the lack of significant foreign investment may limit its growth potential in a competitive market.
Outlook, Risks, and Final Insight
If margins sustain improvement from the recent recovery in sales, Gillanders Arbuthnot may be positioned to enhance profitability and investor confidence. However, the company faces risks, including fluctuating commodity prices in the tea and coffee sectors, which could impact profitability. Additionally, the low interest coverage ratio indicates potential financial strain, making it essential for management to restructure operations and reduce costs. Should the company successfully implement strategies to enhance operational efficiency and maintain sales growth, it could turn the tide in its favor. The balance between leveraging its assets while managing debt will be crucial in navigating the competitive landscape of the plantations industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Gillanders Arbuthnot & Company Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Goodricke Group Ltd | 406 Cr. | 188 | 357/162 | 72.8 | 125 | 0.00 % | 3.22 % | 2.86 % | 10.0 |
Diana Tea Company Ltd | 44.7 Cr. | 29.8 | 46.5/26.0 | 43.0 | 0.00 % | 1.40 % | 7.16 % | 5.00 | |
Bengal Tea & Fabrics Ltd | 122 Cr. | 135 | 196/126 | 102 | 213 | 1.11 % | 5.22 % | 55.3 % | 10.0 |
Bansisons Tea Industries Ltd | 4.10 Cr. | 6.47 | 8.00/5.60 | 9.42 | 0.00 % | 1.01 % | 1.01 % | 10.0 | |
B&A Ltd | 126 Cr. | 407 | 689/0.00 | 13.6 | 455 | 0.00 % | 8.96 % | 6.02 % | 10.0 |
Industry Average | 9,073.88 Cr | 400.10 | 112.10 | 243.71 | 0.40% | 7.88% | 16.74% | 7.00 |
Quarterly Result
Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 124.81 | 143.56 | 103.24 | 77.42 | 87.68 | 105.42 | 101.43 | 68.75 | 84.85 | 126.75 | 127.64 | 103.94 | 88.37 |
Expenses | 121.76 | 119.46 | 101.82 | 94.04 | 90.30 | 96.42 | 125.76 | 84.41 | 90.11 | 101.46 | 119.87 | 106.03 | 88.49 |
Operating Profit | 3.05 | 24.10 | 1.42 | -16.62 | -2.62 | 9.00 | -24.33 | -15.66 | -5.26 | 25.29 | 7.77 | -2.09 | -0.12 |
OPM % | 2.44% | 16.79% | 1.38% | -21.47% | -2.99% | 8.54% | -23.99% | -22.78% | -6.20% | 19.95% | 6.09% | -2.01% | -0.14% |
Other Income | 12.60 | 3.91 | 6.07 | 7.67 | 4.59 | 1.86 | 8.25 | -1.07 | 1.74 | 3.53 | 13.23 | 3.99 | 0.49 |
Interest | 5.24 | 4.39 | 3.99 | 4.42 | 3.98 | 3.51 | 3.94 | 2.86 | 3.46 | 2.85 | 2.95 | 3.10 | 3.24 |
Depreciation | 2.95 | 3.09 | 3.01 | 2.91 | 3.03 | 3.15 | 2.86 | 2.72 | 2.67 | 2.78 | 2.80 | 2.61 | 2.65 |
Profit before tax | 7.46 | 20.53 | 0.49 | -16.28 | -5.04 | 4.20 | -22.88 | -22.31 | -9.65 | 23.19 | 15.25 | -3.81 | -5.52 |
Tax % | 8.58% | 11.89% | -51.02% | -33.54% | 4.37% | 13.33% | -2.32% | 10.49% | 1.76% | 7.37% | 14.56% | -153.54% | -1.27% |
Net Profit | 6.81 | 18.09 | 0.74 | -10.81 | -5.26 | 3.64 | -22.35 | -24.65 | -9.82 | 21.47 | 13.03 | 2.04 | -5.46 |
EPS in Rs | 3.19 | 8.48 | 0.35 | -5.07 | -2.46 | 1.71 | -10.47 | -11.55 | -4.60 | 10.06 | 6.11 | 0.96 | -2.56 |
Last Updated: August 20, 2025, 10:30 am
Below is a detailed analysis of the quarterly data for Gillanders Arbuthnot & Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 88.37 Cr.. The value appears to be declining and may need further review. It has decreased from 103.94 Cr. (Mar 2025) to 88.37 Cr., marking a decrease of 15.57 Cr..
- For Expenses, as of Jun 2025, the value is 88.49 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 106.03 Cr. (Mar 2025) to 88.49 Cr., marking a decrease of 17.54 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.12 Cr.. The value appears strong and on an upward trend. It has increased from -2.09 Cr. (Mar 2025) to -0.12 Cr., marking an increase of 1.97 Cr..
- For OPM %, as of Jun 2025, the value is -0.14%. The value appears strong and on an upward trend. It has increased from -2.01% (Mar 2025) to -0.14%, marking an increase of 1.87%.
- For Other Income, as of Jun 2025, the value is 0.49 Cr.. The value appears to be declining and may need further review. It has decreased from 3.99 Cr. (Mar 2025) to 0.49 Cr., marking a decrease of 3.50 Cr..
- For Interest, as of Jun 2025, the value is 3.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.10 Cr. (Mar 2025) to 3.24 Cr., marking an increase of 0.14 Cr..
- For Depreciation, as of Jun 2025, the value is 2.65 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.61 Cr. (Mar 2025) to 2.65 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Jun 2025, the value is -5.52 Cr.. The value appears to be declining and may need further review. It has decreased from -3.81 Cr. (Mar 2025) to -5.52 Cr., marking a decrease of 1.71 Cr..
- For Tax %, as of Jun 2025, the value is -1.27%. The value appears to be increasing, which may not be favorable. It has increased from -153.54% (Mar 2025) to -1.27%, marking an increase of 152.27%.
- For Net Profit, as of Jun 2025, the value is -5.46 Cr.. The value appears to be declining and may need further review. It has decreased from 2.04 Cr. (Mar 2025) to -5.46 Cr., marking a decrease of 7.50 Cr..
- For EPS in Rs, as of Jun 2025, the value is -2.56. The value appears to be declining and may need further review. It has decreased from 0.96 (Mar 2025) to -2.56, marking a decrease of 3.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:48 pm
Metric | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 355 | 863 | 817 | 681 | 665 | 751 | 660 | 431 | 406 | 449 | 363 | 443 |
Expenses | 333 | 821 | 812 | 653 | 615 | 686 | 632 | 400 | 377 | 437 | 397 | 417 |
Operating Profit | 22 | 42 | 5 | 28 | 50 | 65 | 28 | 31 | 30 | 12 | -34 | 26 |
OPM % | 6% | 5% | 1% | 4% | 7% | 9% | 4% | 7% | 7% | 3% | -9% | 6% |
Other Income | 11 | 9 | 12 | 30 | 21 | 12 | 26 | 7 | 17 | 30 | 14 | 22 |
Interest | 10 | 42 | 51 | 54 | 50 | 50 | 48 | 37 | 23 | 18 | 14 | 12 |
Depreciation | 9 | 21 | 19 | 22 | 24 | 20 | 20 | 16 | 12 | 12 | 12 | 11 |
Profit before tax | 14 | -12 | -53 | -18 | -4 | 7 | -12 | -15 | 11 | 12 | -46 | 25 |
Tax % | 21% | -27% | 4% | 4% | 112% | 95% | 22% | 2% | -42% | -22% | 6% | -7% |
Net Profit | 11 | -9 | -55 | -19 | -9 | 0 | -15 | -16 | 16 | 15 | -49 | 27 |
EPS in Rs | 6.69 | -4.16 | -25.93 | -8.83 | -4.02 | 0.15 | -7.13 | -7.32 | 7.66 | 6.94 | -22.78 | 12.52 |
Dividend Payout % | 25% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -511.11% | 65.45% | 52.63% | 100.00% | -6.67% | 200.00% | -6.25% | -426.67% | 155.10% |
Change in YoY Net Profit Growth (%) | 0.00% | 576.57% | -12.82% | 47.37% | -106.67% | 206.67% | -206.25% | -420.42% | 581.77% |
Gillanders Arbuthnot & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | -6% |
5 Years: | -8% |
3 Years: | 3% |
TTM: | 24% |
Compounded Profit Growth | |
---|---|
10 Years: | 14% |
5 Years: | 21% |
3 Years: | 0% |
TTM: | 139% |
Stock Price CAGR | |
---|---|
10 Years: | 9% |
5 Years: | 34% |
3 Years: | 21% |
1 Year: | 42% |
Return on Equity | |
---|---|
10 Years: | -6% |
5 Years: | -2% |
3 Years: | -4% |
Last Year: | 7% |
Last Updated: September 5, 2025, 4:45 am
Balance Sheet
Last Updated: May 13, 2025, 3:30 pm
Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 11 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
Reserves | 107 | 266 | 155 | 262 | 271 | 268 | 255 | 231 | 248 | 255 | 196 | 224 |
Borrowings | 91 | 456 | 480 | 449 | 424 | 392 | 366 | 227 | 183 | 145 | 129 | 139 |
Other Liabilities | 72 | 242 | 209 | 203 | 225 | 244 | 214 | 145 | 144 | 129 | 130 | 130 |
Total Liabilities | 281 | 985 | 865 | 936 | 942 | 925 | 857 | 624 | 597 | 550 | 477 | 514 |
Fixed Assets | 112 | 421 | 310 | 441 | 432 | 427 | 421 | 315 | 312 | 298 | 263 | 256 |
CWIP | 10 | 11 | 4 | 9 | 17 | 14 | 15 | 14 | 12 | 11 | 9 | 13 |
Investments | 13 | 28 | 28 | 29 | 34 | 29 | 17 | 8 | 3 | 0 | 0 | 0 |
Other Assets | 145 | 525 | 522 | 457 | 460 | 454 | 404 | 287 | 271 | 241 | 205 | 245 |
Total Assets | 281 | 985 | 865 | 936 | 942 | 925 | 857 | 624 | 597 | 550 | 477 | 514 |
Below is a detailed analysis of the balance sheet data for Gillanders Arbuthnot & Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 21.00 Cr..
- For Reserves, as of Mar 2025, the value is 224.00 Cr.. The value appears strong and on an upward trend. It has increased from 196.00 Cr. (Mar 2024) to 224.00 Cr., marking an increase of 28.00 Cr..
- For Borrowings, as of Mar 2025, the value is 139.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 129.00 Cr. (Mar 2024) to 139.00 Cr., marking an increase of 10.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 130.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 130.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 514.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 477.00 Cr. (Mar 2024) to 514.00 Cr., marking an increase of 37.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 256.00 Cr.. The value appears to be declining and may need further review. It has decreased from 263.00 Cr. (Mar 2024) to 256.00 Cr., marking a decrease of 7.00 Cr..
- For CWIP, as of Mar 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2024) to 13.00 Cr., marking an increase of 4.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 245.00 Cr.. The value appears strong and on an upward trend. It has increased from 205.00 Cr. (Mar 2024) to 245.00 Cr., marking an increase of 40.00 Cr..
- For Total Assets, as of Mar 2025, the value is 514.00 Cr.. The value appears strong and on an upward trend. It has increased from 477.00 Cr. (Mar 2024) to 514.00 Cr., marking an increase of 37.00 Cr..
Notably, the Reserves (224.00 Cr.) exceed the Borrowings (139.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -69.00 | -414.00 | -475.00 | -421.00 | -374.00 | -327.00 | -338.00 | -196.00 | -153.00 | -133.00 | -163.00 | -113.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 26 | 56 | 57 | 54 | 53 | 47 | 45 | 54 | 36 | 21 | 29 | 51 |
Inventory Days | 130 | 135 | 156 | 207 | 253 | 219 | 206 | 240 | 389 | 287 | 314 | 225 |
Days Payable | 97 | 92 | 112 | 148 | 180 | 166 | 164 | 163 | 220 | 129 | 164 | 130 |
Cash Conversion Cycle | 59 | 99 | 101 | 113 | 126 | 100 | 87 | 130 | 204 | 179 | 180 | 146 |
Working Capital Days | 72 | -21 | 1 | -6 | -24 | -25 | -47 | -11 | 2 | -1 | -11 | -7 |
ROCE % | 10% | -0% | 1% | 6% | 8% | 4% | 4% | 7% | 4% | -8% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | -22.78 | 6.95 | 7.66 | -7.32 | -7.13 |
Diluted EPS (Rs.) | -22.78 | 6.95 | 7.66 | -7.32 | -7.13 |
Cash EPS (Rs.) | -17.27 | 12.55 | 13.49 | 0.19 | 2.08 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 101.89 | 129.69 | 126.44 | 118.37 | 129.29 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 101.89 | 129.69 | 126.44 | 118.37 | 129.29 |
Revenue From Operations / Share (Rs.) | 170.22 | 210.39 | 190.42 | 201.83 | 309.26 |
PBDIT / Share (Rs.) | -9.36 | 14.78 | 22.12 | 18.70 | 21.23 |
PBIT / Share (Rs.) | -14.87 | 9.18 | 16.29 | 11.19 | 12.02 |
PBT / Share (Rs.) | -21.56 | 5.71 | 5.38 | -7.15 | -5.85 |
Net Profit / Share (Rs.) | -22.78 | 6.95 | 7.66 | -7.32 | -7.13 |
NP After MI And SOA / Share (Rs.) | -22.78 | 6.95 | 7.66 | -7.32 | -7.13 |
PBDIT Margin (%) | -5.50 | 7.02 | 11.61 | 9.26 | 6.86 |
PBIT Margin (%) | -8.73 | 4.36 | 8.55 | 5.54 | 3.88 |
PBT Margin (%) | -12.66 | 2.71 | 2.82 | -3.54 | -1.89 |
Net Profit Margin (%) | -13.38 | 3.30 | 4.02 | -3.62 | -2.30 |
NP After MI And SOA Margin (%) | -13.38 | 3.30 | 4.02 | -3.62 | -2.30 |
Return on Networth / Equity (%) | -22.35 | 5.35 | 6.05 | -6.18 | -5.51 |
Return on Capital Employeed (%) | -12.43 | 6.06 | 9.99 | 6.96 | 6.28 |
Return On Assets (%) | -10.19 | 2.69 | 2.73 | -2.50 | -1.77 |
Long Term Debt / Equity (X) | 0.08 | 0.09 | 0.21 | 0.30 | 0.40 |
Total Debt / Equity (X) | 0.53 | 0.47 | 0.63 | 0.73 | 1.06 |
Asset Turnover Ratio (%) | 0.70 | 0.78 | 0.64 | 0.56 | 0.74 |
Current Ratio (X) | 0.85 | 1.01 | 1.03 | 0.99 | 0.87 |
Quick Ratio (X) | 0.36 | 0.47 | 0.50 | 0.61 | 0.50 |
Inventory Turnover Ratio (X) | 0.52 | 0.78 | 0.95 | 0.57 | 1.13 |
Interest Coverage Ratio (X) | -1.40 | 1.75 | 2.03 | 1.08 | 0.94 |
Interest Coverage Ratio (Post Tax) (X) | -2.41 | 1.23 | 1.70 | 0.63 | 0.48 |
Enterprise Value (Cr.) | 282.86 | 273.58 | 318.10 | 271.78 | 307.23 |
EV / Net Operating Revenue (X) | 0.77 | 0.60 | 0.78 | 0.63 | 0.46 |
EV / EBITDA (X) | -14.15 | 8.67 | 6.74 | 6.81 | 6.78 |
MarketCap / Net Operating Revenue (X) | 0.43 | 0.29 | 0.34 | 0.21 | 0.06 |
Price / BV (X) | 0.71 | 0.47 | 0.51 | 0.36 | 0.14 |
Price / Net Operating Revenue (X) | 0.43 | 0.29 | 0.34 | 0.21 | 0.06 |
EarningsYield | -0.31 | 0.11 | 0.11 | -0.16 | -0.37 |
After reviewing the key financial ratios for Gillanders Arbuthnot & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is -22.78. This value is below the healthy minimum of 5. It has decreased from 6.95 (Mar 23) to -22.78, marking a decrease of 29.73.
- For Diluted EPS (Rs.), as of Mar 24, the value is -22.78. This value is below the healthy minimum of 5. It has decreased from 6.95 (Mar 23) to -22.78, marking a decrease of 29.73.
- For Cash EPS (Rs.), as of Mar 24, the value is -17.27. This value is below the healthy minimum of 3. It has decreased from 12.55 (Mar 23) to -17.27, marking a decrease of 29.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 101.89. It has decreased from 129.69 (Mar 23) to 101.89, marking a decrease of 27.80.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 101.89. It has decreased from 129.69 (Mar 23) to 101.89, marking a decrease of 27.80.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 170.22. It has decreased from 210.39 (Mar 23) to 170.22, marking a decrease of 40.17.
- For PBDIT / Share (Rs.), as of Mar 24, the value is -9.36. This value is below the healthy minimum of 2. It has decreased from 14.78 (Mar 23) to -9.36, marking a decrease of 24.14.
- For PBIT / Share (Rs.), as of Mar 24, the value is -14.87. This value is below the healthy minimum of 0. It has decreased from 9.18 (Mar 23) to -14.87, marking a decrease of 24.05.
- For PBT / Share (Rs.), as of Mar 24, the value is -21.56. This value is below the healthy minimum of 0. It has decreased from 5.71 (Mar 23) to -21.56, marking a decrease of 27.27.
- For Net Profit / Share (Rs.), as of Mar 24, the value is -22.78. This value is below the healthy minimum of 2. It has decreased from 6.95 (Mar 23) to -22.78, marking a decrease of 29.73.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -22.78. This value is below the healthy minimum of 2. It has decreased from 6.95 (Mar 23) to -22.78, marking a decrease of 29.73.
- For PBDIT Margin (%), as of Mar 24, the value is -5.50. This value is below the healthy minimum of 10. It has decreased from 7.02 (Mar 23) to -5.50, marking a decrease of 12.52.
- For PBIT Margin (%), as of Mar 24, the value is -8.73. This value is below the healthy minimum of 10. It has decreased from 4.36 (Mar 23) to -8.73, marking a decrease of 13.09.
- For PBT Margin (%), as of Mar 24, the value is -12.66. This value is below the healthy minimum of 10. It has decreased from 2.71 (Mar 23) to -12.66, marking a decrease of 15.37.
- For Net Profit Margin (%), as of Mar 24, the value is -13.38. This value is below the healthy minimum of 5. It has decreased from 3.30 (Mar 23) to -13.38, marking a decrease of 16.68.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is -13.38. This value is below the healthy minimum of 8. It has decreased from 3.30 (Mar 23) to -13.38, marking a decrease of 16.68.
- For Return on Networth / Equity (%), as of Mar 24, the value is -22.35. This value is below the healthy minimum of 15. It has decreased from 5.35 (Mar 23) to -22.35, marking a decrease of 27.70.
- For Return on Capital Employeed (%), as of Mar 24, the value is -12.43. This value is below the healthy minimum of 10. It has decreased from 6.06 (Mar 23) to -12.43, marking a decrease of 18.49.
- For Return On Assets (%), as of Mar 24, the value is -10.19. This value is below the healthy minimum of 5. It has decreased from 2.69 (Mar 23) to -10.19, marking a decrease of 12.88.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 23) to 0.08, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.53. This value is within the healthy range. It has increased from 0.47 (Mar 23) to 0.53, marking an increase of 0.06.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.70. It has decreased from 0.78 (Mar 23) to 0.70, marking a decrease of 0.08.
- For Current Ratio (X), as of Mar 24, the value is 0.85. This value is below the healthy minimum of 1.5. It has decreased from 1.01 (Mar 23) to 0.85, marking a decrease of 0.16.
- For Quick Ratio (X), as of Mar 24, the value is 0.36. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 23) to 0.36, marking a decrease of 0.11.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.52. This value is below the healthy minimum of 4. It has decreased from 0.78 (Mar 23) to 0.52, marking a decrease of 0.26.
- For Interest Coverage Ratio (X), as of Mar 24, the value is -1.40. This value is below the healthy minimum of 3. It has decreased from 1.75 (Mar 23) to -1.40, marking a decrease of 3.15.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -2.41. This value is below the healthy minimum of 3. It has decreased from 1.23 (Mar 23) to -2.41, marking a decrease of 3.64.
- For Enterprise Value (Cr.), as of Mar 24, the value is 282.86. It has increased from 273.58 (Mar 23) to 282.86, marking an increase of 9.28.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.60 (Mar 23) to 0.77, marking an increase of 0.17.
- For EV / EBITDA (X), as of Mar 24, the value is -14.15. This value is below the healthy minimum of 5. It has decreased from 8.67 (Mar 23) to -14.15, marking a decrease of 22.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.43. This value is below the healthy minimum of 1. It has increased from 0.29 (Mar 23) to 0.43, marking an increase of 0.14.
- For Price / BV (X), as of Mar 24, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 23) to 0.71, marking an increase of 0.24.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.43. This value is below the healthy minimum of 1. It has increased from 0.29 (Mar 23) to 0.43, marking an increase of 0.14.
- For EarningsYield, as of Mar 24, the value is -0.31. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 23) to -0.31, marking a decrease of 0.42.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gillanders Arbuthnot & Company Ltd:
- Net Profit Margin: -13.38%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -12.43% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -22.35% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -2.41
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.36
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 12.9 (Industry average Stock P/E: 112.1)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.53
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -13.38%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Plantations - Tea & Coffee | C-4, Gillander House, Netaji Subhas Road Kolkata West Bengal 700001 | secretarial@gillandersarbuthnot.com http://www.gillandersarbuthnot.com |
Management | |
---|---|
Name | Position Held |
Mr. Arun Kumar Kothari | Chairman |
Mr. Mahesh Sodhani | Managing Director & CEO |
Mrs. Prabhawati Devi Kothari | Non Executive Director |
Mr. Arvind Baheti | Independent Director |
Mr. Charudatta Raghvendra Prayag | Independent Director |
Mr. Kothaneth Ashok | Independent Director |
FAQ
What is the intrinsic value of Gillanders Arbuthnot & Company Ltd?
Gillanders Arbuthnot & Company Ltd's intrinsic value (as of 13 October 2025) is 82.68 which is 34.38% lower the current market price of 126.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹269 Cr. market cap, FY2025-2026 high/low of 152/80.2, reserves of ₹224 Cr, and liabilities of 514 Cr.
What is the Market Cap of Gillanders Arbuthnot & Company Ltd?
The Market Cap of Gillanders Arbuthnot & Company Ltd is 269 Cr..
What is the current Stock Price of Gillanders Arbuthnot & Company Ltd as on 13 October 2025?
The current stock price of Gillanders Arbuthnot & Company Ltd as on 13 October 2025 is 126.
What is the High / Low of Gillanders Arbuthnot & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gillanders Arbuthnot & Company Ltd stocks is 152/80.2.
What is the Stock P/E of Gillanders Arbuthnot & Company Ltd?
The Stock P/E of Gillanders Arbuthnot & Company Ltd is 12.9.
What is the Book Value of Gillanders Arbuthnot & Company Ltd?
The Book Value of Gillanders Arbuthnot & Company Ltd is 115.
What is the Dividend Yield of Gillanders Arbuthnot & Company Ltd?
The Dividend Yield of Gillanders Arbuthnot & Company Ltd is 0.00 %.
What is the ROCE of Gillanders Arbuthnot & Company Ltd?
The ROCE of Gillanders Arbuthnot & Company Ltd is 6.80 %.
What is the ROE of Gillanders Arbuthnot & Company Ltd?
The ROE of Gillanders Arbuthnot & Company Ltd is 6.83 %.
What is the Face Value of Gillanders Arbuthnot & Company Ltd?
The Face Value of Gillanders Arbuthnot & Company Ltd is 10.0.